Nootropiques / Soutien cognitif

At a Glance

Overview

The Basics

Cognitive support is an outcome category, not one mechanism.

This collection gathers compounds that appear in the same brain-health conversations, but the local KB breaks them into distinct lanes:

• anxiolytic / nootropic lane: Selank, Semax
• neurotrophic / memory lane: Dihexa, Pinealon, with Semax overlapping
• sleep-regulation lane: DSIP, Epithalon
• non-peptide mitochondrial / redox lane: NAD+, Methylene Blue
• redox bridge: Glutathione

The blend slug Dihexa / Methylene Blue / Tesofensine sits on top of those lanes as a commercial hybrid, not as an evidence-equal core member.

The Science

The anxiolytic / nootropic lane is built around complementary rather than identical biology. Selank modulates GABAergic tone, monoamines, and BDNF while preserving calm cognition. Semax increases BDNF-linked and monoaminergic cognitive drive with much stronger neuroprotective and cerebrovascular framing.

The neurotrophic / memory lane is more speculative. Dihexa is the most ambitious synaptogenesis story, but the 2025 retraction of its foundational HGF/c-Met paper materially weakens confidence. Pinealon targets neuronal gene expression, antioxidant defense, and serotonin-synthesis pathways, but remains tied to single-network Khavinson literature. Semax overlaps this lane with a stronger clinical base than either.

The sleep-regulation lane is biologically distinct from the daytime nootropic lane. DSIP acts on sleep architecture and slow-wave depth. Epithalon acts through melatonin restoration and circadian regulation, with sleep as the clearest near-term signal and longevity claims remaining more controversial.

The mitochondrial / redox lane is explicitly non-peptide in its core members. NAD+ is a coenzyme, not a peptide. Methylene Blue is a redox-active phenothiazine drug, not a peptide. Both influence cognition indirectly through energy handling and redox biology, but they do so through fundamentally different chemistry and risk profiles.

Glutathione belongs beside that lane as a tripeptide antioxidant bridge. It supports redox conditions that neuronal and mitochondrial function depend on, but it is not a core nootropic signaler.

Mechanism Clusters & Synergy Analysis

The Basics

The most useful collection logic is lane separation, not stack accumulation.

Selank and Semax form the clearest genuine pairing motif. Dihexa and Pinealon extend the neuroplasticity and memory discussion, but with weaker evidence and more uncertainty. DSIP and Epithalon support cognition through sleep depth and circadian timing rather than through acute task performance. NAD+ and Methylene Blue support mitochondrial and redox biology without behaving like peptides. Glutathione supports the oxidative environment around all of those lanes without functioning as a primary cognitive enhancer.

The Science

The strongest conceptual synergy in the collection is the Selank plus Semax pair. Semax supplies BDNF-linked nootropic drive, dopamine and serotonin modulation, and the best human neuroprotection data on the page. Selank reduces anxiety load through indirect GABAergic and enkephalinase mechanisms while preserving clarity. That pairing maps onto both local KB framing and community use without requiring exaggerated protocol claims.

The neurotrophic-memory lane is less stable. Dihexa proposes structural synaptogenesis and long-duration cognitive gains, but mechanism credibility is materially reduced after the 2025 retraction and the failed clinical trajectory of fosgonimeton. Pinealon offers antioxidant gene upregulation, neuronal stress resistance, and memory-protection framing, but it remains early and weakly replicated. Semax is again the stabilizing member because its BDNF and cognition claims rest on stronger clinical footing.

The sleep-regulation lane should stay separate from the nootropic lane. DSIP biases sleep architecture toward slow-wave and REM quality in responders, while Epithalon aims at circadian repair and melatonin restoration. Their cognitive relevance is indirect but real: sleep depth, recovery timing, and circadian stability can improve next-day function without converting those compounds into direct focus agents.

The non-peptide mitochondrial / redox lane is narrower than the collection title suggests. NAD+ supports the redox economy and sirtuin-linked energy handling that brain tissue depends on. Methylene Blue can bypass damaged electron-transport bottlenecks and alter monoamine clearance through MAO-A inhibition. Those mechanisms can improve focus or fatigue in some contexts, but they also bring sleep, cardiovascular, and drug-interaction constraints that do not belong to the peptide nootropic lane.

The blend slug Dihexa / Methylene Blue / Tesofensine demonstrates the outer limit of this taxonomy. It combines speculative neuroplasticity, redox pharmacology, and stimulant-like monoamine reuptake inhibition into one marketed object. The local KB supports classification, not normalization.

Key Benefits & Goal Framing

The Basics

This collection serves five different goal frames:

• reducing anxious cognitive interference
• increasing focus and cognitive stamina
• supporting memory and neuroplasticity
• improving sleep architecture or circadian timing
• supporting mitochondrial and redox biology that can shape cognition indirectly

That structure is more accurate than a single “brain optimization” label.

The Science

Goal framing by lane:

• Calm cognition and stress-threshold support: Selank
• Focus, mental clarity, and neuroprotective nootropic support: Semax
• High-risk, high-interest neuroplasticity and memory framing: Dihexa
• Long-horizon memory and neuronal resilience framing: Pinealon
• Sleep architecture support: DSIP
• Circadian repair and melatonin restoration: Epithalon
• Mitochondrial and redox cofactor support: NAD+
• Redox-active mitochondrial rescue with cognition-adjacent effects: Methylene Blue
• Foundational antioxidant and redox buffering: Glutathione
• Commercial hybrid logic rather than validated protocol logic: Dihexa / Methylene Blue / Tesofensine

The weakest framing on the page is a single all-purpose smart-drug stack that treats all 10 entries as interchangeable.

Evidence Summary

The Basics

The evidence hierarchy on this page is uneven.

Semax has the strongest cognition and neuroprotection footing because it has decades of Russian clinical use plus the clearest human data in stroke, cognitive recovery, and neurotrophin-linked outcome framing. Selank has the strongest anxiety-specific clinical niche and the clearest “calm without sedation” identity. DSIP has older but real human sleep data, though mixed. Epithalon has a stronger sleep and circadian story than a lifespan story. NAD+, Methylene Blue, and Glutathione have meaningful biological relevance, but cognition is either indirect or highly context-dependent. Dihexa and Pinealon remain the most speculative of the true cognitive peptides. The blend slug sits below all of them.

The Science

Evidence calibration across the page:

• Strongest clinical neuroprotection and cognition member: Semax
• Strongest clinical anxiolytic member: Selank
• Moderate but old human sleep signal: DSIP
• Moderate circadian and sleep signal with weaker longevity certainty: Epithalon
• Biologically credible but indirect cognition support: NAD+, Glutathione
• Real pharmacology with meaningful safety complexity: Methylene Blue
• Speculative neurotrophic-memory member with major caveats: Dihexa
• Speculative memory and neuroprotection member with narrow replication: Pinealon
• Most weakly supported as a standalone evidence object: Dihexa / Methylene Blue / Tesofensine

Component Highlights

Quick links: DSIP, Dihexa, Dihexa / Methylene Blue / Tesofensine, Epithalon, Glutathione, Methylene Blue, NAD+, Pinealon, Selank, Semax.

Selank

Selank is the anxiolytic anchor. It belongs on the page because it lowers anxious interference without sedation, withdrawal, or cognitive dulling, making it the clearest calm-cognition peptide in the collection.

Semax

Semax is the nootropic and neuroprotective anchor. It has the best local evidence for focus, mental clarity, and neurotrophic support, and it bridges the anxiolytic/nootropic lane with the neurotrophic-memory lane.

Dihexa

Dihexa is the structural neuroplasticity entry. It remains compelling in theory, but its mechanistic story is materially weaker after the foundational 2025 retraction and the lack of completed human trials.

Pinealon

Pinealon is the long-horizon memory and neuronal-resilience entry. It is better framed as neuroprotective gene-expression support than as an acute productivity enhancer.

DSIP

DSIP is the sleep-architecture entry. It is relevant to cognition because slow-wave and REM quality can improve next-day function, not because DSIP behaves like a daytime nootropic.

Epithalon

Epithalon is the circadian-repair entry. Its most defensible cognitive relevance comes from melatonin restoration and sleep timing rather than from direct nootropic effects.

NAD+

NAD+ is not a peptide. It belongs here as a non-peptide cofactor support member because neuronal energy handling, sirtuin activity, and mitochondrial throughput can shape fatigue and brain-fog outcomes.

Methylene Blue

Methylene Blue is not a peptide. It is the highest-caution cognition-adjacent redox drug on the page because its focus and mood benefits sit next to MAOI interaction risk and a narrow hormetic window.

Glutathione

Glutathione is the redox bridge. It is chemically a tripeptide, but its collection role is foundational antioxidant support rather than direct nootropic signaling.

Dihexa / Methylene Blue / Tesofensine

This blend is a platform-defined commercial hybrid rather than a validated stack. It combines speculative neuroplasticity, redox pharmacology, and a non-peptide monoamine reuptake inhibitor in one slug, which is useful as taxonomy context and weak as evidence.

Comparative Analysis

The Basics

The shortest useful reading of the page is:

• Selank = calm cognition
• Semax = activating nootropic and neuroprotection
• Dihexa = speculative synaptogenesis and memory
• Pinealon = speculative neuroprotection and memory maintenance
• DSIP = sleep architecture
• Epithalon = circadian repair
• NAD+ = non-peptide cofactor support
• Methylene Blue = non-peptide redox drug
• Glutathione = antioxidant bridge
• blend slug = commercial hybrid logic

That comparison is more accurate than treating every member as another smart peptide.

The Science

Comparison by function:

• For anxiety reduction without sedation: Selank
• For the strongest clinical nootropic and neuroprotective footing: Semax
• For ambitious but weakly validated neuroplasticity claims: Dihexa
• For epigenetic neuroprotection and memory-maintenance framing: Pinealon
• For sleep-depth and slow-wave framing: DSIP
• For melatonin and circadian restoration: Epithalon
• For non-peptide energy and redox support: NAD+
• For non-peptide redox-active mitochondrial rescue with drug-interaction risk: Methylene Blue
• For foundational antioxidant buffering: Glutathione
• For marketed combination logic rather than validated synergy: Dihexa / Methylene Blue / Tesofensine

Selection Logic

The Basics

Collection navigation works best when the dominant lane is identified before member comparison.

Anxiety-dominant cognition questions map toward Selank. Focus and neuroprotection questions map toward Semax. Memory-plasticity questions map toward Dihexa and Pinealon, but only with heavier evidence caveats. Sleep-depth questions map toward DSIP. Circadian and melatonin questions map toward Epithalon. Brain-fog and energy-handling questions map toward the explicitly non-peptide lane of NAD+ and Methylene Blue, with Glutathione supporting the oxidative-stress layer.

The Science

A practical hierarchy for the page is:

1. Separate calm-cognition peptides from activating nootropics.
2. Separate neuroplasticity stories from sleep and circadian stories.
3. Separate peptide cognition members from the non-peptide mitochondrial / redox lane.
4. Hold the blend slug apart as a commercial hybrid rather than a core evidence object.

That hierarchy preserves both chemistry honesty and evidence honesty.

General Dosing Considerations

The Basics

This collection is not suitable as one shared dosing template.

The members span intranasal Russian nootropics, short-course sleep peptides, speculative neurotrophic compounds with uncertain human translation, injectable and oral redox compounds, and one commercial blend slug with no standalone local KB guide. Those are different protocol languages.

The Science

Dosing remains member-specific because the page contains:

• anxiolytic and nootropic peptides that often use short intranasal or subcutaneous cycles
• sleep and circadian peptides whose timing matters at least as much as dose
• neurotrophic compounds where human dose-finding remains weak or absent
• non-peptide mitochondrial compounds with route-dependent tolerability and interaction burdens
• a redox tripeptide whose role is foundational rather than acutely cognitive

The collection-level task is mechanism comparison, not schedule design.

Safety Notes

The Basics

The highest-risk collection error is mechanism flattening.

Calming peptides, stimulating nootropics, sleep peptides, and redox drugs carry different failure modes. The page is strongest when those failure modes stay visible.

The Science

The main collection-wide caution points are:

• NAD+ and Methylene Blue are not peptides.
• Methylene Blue carries MAOI and serotonin-syndrome risk.
• the tesofensine component of the blend adds monoamine and cardiovascular caution.
• Dihexa carries mechanism uncertainty plus tumor-signaling concern in theory.
• Pinealon and Epithalon remain dependent on narrower research traditions than Semax or Selank.
• DSIP supports sleep architecture but does not act like a standard sedative and has a high non-responder rate.

Related Guides

• Selank
• Semax
• DSIP
• Epithalon
• Dihexa
• Pinealon
• NAD+
• Methylene Blue
• Glutathione